Profil
Michael Griffith served as President & Chief Executive Officer at Bluebird Biosciences, Inc. He was also Vice President-Scientific Affairs at Baxter International, Inc. from 1985 to 1998.
He served as Vice President-Product Development at Nexell Therapeutics, Inc. and as President & Chief Scientific Officer at Inspiration Biopharmaceuticals, Inc. Dr. Griffith holds a doctorate degree from The University of Texas at Austin.
Ehemalige bekannte Positionen von Michael Griffith
| Unternehmen | Position | Ende |
|---|---|---|
| BAXTER INTERNATIONAL INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Präsident | - |
Nexell Therapeutics, Inc.
 Nexell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexell Therapeutics, Inc. develops, manufactures and markets pharmaceutical therapies. Its cell therapy is used for the treatment of genetic blood disorders, autoimmune diseases, cancer, and regenerative medicine applications. The company is headquartered in Irvine, CA. | Corporate Officer/Principal | - |
| Bluebird Biosciences, Inc. | Präsident | - |
Ausbildung von Michael Griffith
| The University of Texas at Austin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Bluebird Biosciences, Inc. | |
Nexell Therapeutics, Inc.
Nexell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexell Therapeutics, Inc. develops, manufactures and markets pharmaceutical therapies. Its cell therapy is used for the treatment of genetic blood disorders, autoimmune diseases, cancer, and regenerative medicine applications. The company is headquartered in Irvine, CA. | Health Technology |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Health Technology |
